Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose

K. Amrein, G. Schilcher, A. Fahrleitner-Pammer
European Respiratory Journal 2011 37: 470-471; DOI: 10.1183/09031936.00136910
K. Amrein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: karin.amrein@medunigraz.at
G. Schilcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Fahrleitner-Pammer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

The risk of occurrence of hypercalcaemia induced by vitamin D in certain conditions has recently been summarised by Kallas et al. 1. Despite the high prevalence of vitamin D deficiency among the healthy population and observational associations with cardiovascular disease, autoimmune diseases, some types of cancer, tuberculosis and mortality 2, 3, there are currently no data to justify widespread use of vitamin D supplementation, taking into account the lack of large prospective randomised controlled trials.

We would like to share our experience with calcitriol-mediated hypercalcaemia in an apparently healthy individual. A 26-yr-old obese female with a body mass index of 48.4 kg·m−2 was transferred to the endocrinology outpatient clinic of the Medical University of Graz (Graz, Austria) for evaluation of metabolic syndrome before bariatric surgery. Severe vitamin D deficiency was noted during the routine laboratory tests, and the patient received an oral loading dose of 180,000 IU cholecalciferol followed by 2,000 IU daily.

6 weeks later, the patient was sent to the nephrology outpatient clinic for evaluation of asymptomatic hypercalcaemia and hypercalciuria. Laboratory investigation demonstrated an increased 1,25-dihydroxyvitamin D (1,25-(OH)2-D) and suppressed parathyroid hormone (PTH) level (table 1).

View this table:
  • View inline
  • View popup
Table 1– Overview of laboratory findings

During the ensuing work-up, stage I sarcoidosis was diagnosed by chest radiography, with bilateral hilar lymphadenopathy. High angiotensin-converting enzyme levels (176.7 U·L−1; normal range 20–70 U·L−1) and cytological samples from bronchoscopy with typical histopathological findings confirmed the diagnosis of sarcoidosis. 5 weeks after the initial diagnosis of hypercalcaemia and withdrawal of oral cholecalciferol, calcium levels had normalised (ionised calcium 1.26 M) and the 25-hydroxyvitamin D (25-OH-D) level was in the upper normal range, whereas levels of 1,25-(OH)2-D were still elevated and of PTH remained suppressed (table 1).

Vitamin D deficiency is highly prevalent, especially in obese individuals 4, but also in respiratory disease 5, 6. Although vitamin D has a low-risk profile and a broad therapeutic window, we suggest that the use of vitamin D in healthy individuals outside of clear indications or clinical trials should be questioned for two reasons: first, there are currently no large prospective randomised controlled trials showing that vitamin D supplementation leads to beneficial outcomes; and, secondly, because of the potential risk of calcitriol-mediated hypercalcaemia that may arise from a variety of potentially unrecognised or asymptomatic conditions, as in the present patient. Asymptomatic sarcoidosis, especially in stage I, is not uncommon 7. Vitamin D and calcium metabolism is abnormal in sarcoidosis. A Japanese group reported hypercalcaemia in 7% of newly diagnosed patients 8, whereas, in the ACCESS (A Case Control Etiologic Study of Sarcoidosis) cohort, hypercalcaemia and/or hypercalciuria were found in 4% of recently diagnosed patients 9 even without concomitant vitamin D therapy. Calcitriol-induced hypercalcaemia can occur in sarcoidosis when macrophages are challenged with sudden availability of the substrate 25-OH-D because pulmonary alveolar macrophages possess a 1α-hydroxylase and are able to produce 1,25-(OH)2-D. Furthermore, the feedback mechanism seems to be less effective 6.

Although vitamin D is an important immunomodulator that may have a positive effect in patients with sarcoidosis 10, vitamin D loading doses are not recommended and vitamin D repletion must be undertaken with great care 6.

We think it is important to carefully weigh the risk/benefit ratio and consider the risk of hypercalcaemia in apparently healthy patients on vitamin D therapy. Therefore, calcium levels should be checked regularly when administering vitamin D, since hypercalcaemia is often asymptomatic.

Footnotes

  • Statement of Interest

    None declared.

  • ©ERS 2011

REFERENCES

  1. ↵
    1. Kallas M,
    2. Green F,
    3. Hewison M,
    4. et al
    . Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 2010; 95: 3111–3117.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Adams JS,
    2. Hewison M
    . Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471–478.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Melamed ML,
    2. Michos ED,
    3. Post W,
    4. et al
    . 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629–1637.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. McGill AT,
    2. Stewart JM,
    3. Lithander FE,
    4. et al
    . Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7: 4–
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kunisaki KM,
    2. Niewoehner DE,
    3. Singh RJ,
    4. et al
    . Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J 2011:37: 238–243.
  6. ↵
    1. Burke RR,
    2. Rybicki BA,
    3. Rao DS
    . Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med 2010; 31: 474–484.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Lynch JP 3rd.,
    2. Ma YL,
    3. Koss MN,
    4. et al
    .Pulmonary sarcoidosis. Semin Respir Crit Care Med 2007; 28: 53–74.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Morimoto T,
    2. Azuma A,
    3. Abe S,
    4. et al
    . Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31: 372–379.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Baughman RP,
    2. Teirstein AS,
    3. Judson MA,
    4. et al
    . Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885–1889.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Richmond BW,
    2. Drake WP
    . Vitamin D, innate immunity, and sarcoidosis granulomatous inflammation: insights from mycobacterial research. Curr Opin Pulm Med 2010; 16: 461–464.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 37 Issue 2 Table of Contents
European Respiratory Journal: 37 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose
K. Amrein, G. Schilcher, A. Fahrleitner-Pammer
European Respiratory Journal Feb 2011, 37 (2) 470-471; DOI: 10.1183/09031936.00136910

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose
K. Amrein, G. Schilcher, A. Fahrleitner-Pammer
European Respiratory Journal Feb 2011, 37 (2) 470-471; DOI: 10.1183/09031936.00136910
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Drug concentration in lung tissue in MDR-TB
  • Obesity in COPD: the effect of water-based exercise
  • Burden of CAP in Italian general practice
Show more Letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society